New Technologies and Building Successful Biotechnology Companies to Treat Disease

This event will explore how fundamental scientific discovery can be translated into real‑world benefit and the role universities play in supporting that journey with integrity, responsibility, and long‑term vision.

Celebrating his return to Cambridge and the MRC Laboratory of Molecular Biology (LMB), we are delighted to welcome Professor Harvey Lodish, Professor of Biology and Biological Engineering at MIT, who undertook his postdoctoral research at the LMB with Drs Sydney Brenner and Francis Crick, for a special lecture and discussion.

Professor Lodish will share insights from his academic career and his experience co-founding co-founding biotechnology companies Genzyme and Millennium Pharmaceuticals, including perspectives on mentorship, ethics, and the relationship between research excellence and commercialising technology. The lecture will be followed by a panel discussion, Q&A, and networking over lunch.

This unique opportunity is open to academics, postdoctoral researchers, and staff from across the Biomedical Campus, including the LMB, Clinical Schools, Milner Therapeutics Institute, and partner organisations.